A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- United Therapeutics
- Study ID
- NCT03626688
- Phase
- PHASE3
- Status
- Completed
Conditions
- Cardiovascular Diseases
- Connective Tissue Diseases
- Familial Primary Pulmonary Hypertension
- Hypertension
- Hypertension, Pulmonary
- Lung Diseases
- PAH
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension
- Respiratory Tract Disease
- Vascular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ralinepag — DRUGActive
- Placebo — DRUGPlacebo
Study Details
Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.
Key Dates
- Start date
- Aug 30, 2018
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 687 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RalinepagRalinepag once daily extended-release tablets (oral) 50, 250, and 400 mcg titrated to the highest tolerated dose.
- Placebo Comparator: PlaceboMatching placebo tablets (oral)
Primary Outcome Measure
Time from randomization to the first adjudicated protocol-defined clinical worsening event [ Time Frame: The study duration was event-based. This parameter was assessed from randomization until the conclusion of the study, up to 3 years ]
Locations (68)
Find similar trials in Birmingham, AL
By condition
By specialty
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Natural History of Stroke: Cause and DevelopmentRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Washington D.C., District of Columbia
- Cardiovascular BiorepositoryEnrolling By Invitation · Kenneth S. Campbell · Lexington, Kentucky
- Effect of Electro-Acupuncture on Blood PressureRecruiting · University of California, Irvine · Irvine, California